Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07819097
What this trial is testing

Learn About the Safety and Immune Responses of RSVpreF in Older Adults

Who this might be right for
AdultHealthy Participants
Pfizer 600
Large-scale testing (Phase 3)Ended earlyNCT06079320
What this trial is testing

Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 16
Not applicableStudy completedNCT03062917
What this trial is testing

Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis

Who this might be right for
BronchiolitisBronchiolitis, ViralRSV Infection+1 more
Imperial College Healthcare NHS Trust 152
Early research (Phase 1)UnknownNCT03436225
What this trial is testing

Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.

Who this might be right for
Bronchiolitis; Respiratory Syncytial Virus
Assiut University 80
Not applicableStudy completedNCT01224691
What this trial is testing

TGF-(Beta) and Susceptibility to RSV

Who this might be right for
Asthma
National Institute of Environmental Health Sciences (NIEHS) 113
Testing effectiveness (Phase 2)Study completedNCT02309320
What this trial is testing

A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171

Who this might be right for
Respiratory Syncytial Virus Infection
Ablynx, a Sanofi company 53
Large-scale testing (Phase 3)Study completedNCT05705440
What this trial is testing

A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 3,855
Early research (Phase 1)Study completedNCT02478333
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT02115815
What this trial is testing

Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults

Who this might be right for
Respiratory Syncytial Virus (RSV)
MedImmune LLC 246
Large-scale testing (Phase 3)Ended earlyNCT05242432
What this trial is testing

Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

Who this might be right for
Respiratory Syncytial Virus Prevention
Janssen Pharmaceutical K.K. 2,192
Not applicableStudy completedNCT02016690
What this trial is testing

Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®

Who this might be right for
Respiratory Syncytial Virus Infection
AbbVie 312
Not applicableStudy completedNCT00369759
What this trial is testing

An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants

Who this might be right for
Respiratory InfectionsBronchiolitisPneumonia+1 more
MedImmune LLC 2,048
Large-scale testing (Phase 3)Looking for participantsNCT07653100
What this trial is testing

Study in India to Describe the Safety and Immunogenicity of RSVpreF

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 540
Large-scale testing (Phase 3)Study completedNCT07117487
What this trial is testing

MRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 507
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Not applicableUnknownNCT06175611
What this trial is testing

Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection

Who this might be right for
SARS-CoV2 InfectionInfluenza AInfluenza B+1 more
EDAN Instruments Inc. 1,000
Early research (Phase 1)Study completedNCT01805921
What this trial is testing

RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.

Who this might be right for
Respiratory Syncytial Virus Infections
ReiThera Srl 72
Testing effectiveness (Phase 2)Study completedNCT02135614
What this trial is testing

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Gilead Sciences 189
Early research (Phase 1)Study completedNCT04444284
What this trial is testing

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 34
Early research (Phase 1)Study completedNCT02472548
What this trial is testing

Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine

Who this might be right for
Respiratory Syncytial Virus
Dalhousie University 40
Next Page